Mixlab, a veterinary pharmacy startup, has recently raised $10 million in funding to expand its services and reach more pet owners. The company, founded in 2020, aims to make it easier for pet owners to get the medications their furry friends need.
The funding round was led by Sonoma Brands, with participation from Global Founders Capital, Brand Foundry Ventures, and others. This brings Mixlab’s total funding to $14.5 million.
Mixlab’s mission is to simplify the process of getting medications for pets. Currently, pet owners have to go to a traditional pharmacy to get their pet’s medications, which can be time-consuming and inconvenient. Mixlab offers a more convenient solution by delivering the medications directly to the pet owner’s doorstep.
The company also offers personalized dosing and compounding services, which are especially helpful for pets with unique needs or those who are difficult to medicate. Mixlab’s team of pharmacists and veterinarians work together to create customized medications for each pet, ensuring that they receive the proper dosage and form of medication.
Mixlab’s services have become even more crucial during the COVID-19 pandemic, as many pet owners have been unable to visit their veterinarian in person. With Mixlab, pet owners can consult with a veterinarian remotely and have their pet’s medications delivered to their home, eliminating the need for in-person visits.
The company has seen significant growth since its launch, with a 300% increase in revenue in the past year. This funding will allow Mixlab to expand its services to more cities and states, as well as invest in technology to improve its platform and streamline the ordering process.
Mixlab’s CEO and co-founder, Fred Dijols, stated, “We are thrilled to have the support of our investors as we continue to grow and improve our services for pet owners. Our goal is to make the process of getting medications for pets as easy and stress-free as possible, and this funding will help us reach even more pet owners in need.”
The veterinary pharmacy market is estimated to be worth $9.3 billion, and Mixlab is well-positioned to disrupt this industry with its innovative approach. The company plans to use the funding to expand its team and partnerships with veterinarians, as well as invest in marketing efforts to increase awareness of its services.
Mixlab’s success is a testament to the growing demand for convenient and personalized healthcare services for pets. With this latest funding, the company is poised for even more growth and has the potential to become a leader in the veterinary pharmacy space.
